A state-transition model demonstrates that multicancer early detection blood tests significantly reduce late-stage cancer diagnoses and mortality, with annual screening intervals showing superior outcomes compared to biennial testing.
New research finds GLP-1 receptor agonists significantly reduce hematologic malignancy risk in patients with type 2 diabetes compared to insulin therapy, with up to 81% lower risk for certain malignancies.
Guest Editor’s Note: Several epidemiologic studies have shown an inverse association between healthy dietary patterns and the risk of chronic diseases including cancer. Patients are often interested i...
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers tracked over 10,000 patients and found the risk of self-harm was highest before starting gabapentinoids and again shortly after stopping, highlighting key periods for clinical monitoring.
A study of nearly 19,000 ICU patients found that a higher triglyceride-glucose (TyG) index was linked to significantly increased 28-day mortality, with risk doubling once the index passed a threshold of 8.82.
A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.